The pharmaceutical industry spends more on marketing than on research, and this film tracks where that money goes. Interviews with physicians, former drug reps, and critics including Marcia Angell, past editor of the New England Journal of Medicine, lay out how direct-to-consumer advertising, legalized in the United States in 1997, turned prescription drugs into products sold the way cars and soft drinks are sold. The film walks through the mechanics of "disease mongering": conditions like restless leg syndrome and social anxiety disorder get named, publicized, and matched to a pill almost simultaneously, often with the same company funding the awareness campaign and the drug. Archival ads, medical journal excerpts, and congressional testimony fill out the case that patients now arrive at appointments asking for brand names they saw on television, reversing the traditional doctor-patient relationship. The film's target is the business model itself, and it makes a plain, well-sourced argument that the industry profits by expanding the definition of illness rather than curing it.